Expertise in
7
conditions

Gemma G. Kenter

Amsterdam, NH, NL 
Expertise in
7
conditions
Amsterdam, NH, NL 

Overview

Gemma Kenter practices practicing medicine in Amsterdam, Netherlands.

Ms. Kenter is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Cervical Cancer, Ovarian Cancer, Cervical Dysplasia, Salpingo-Oophorectomy, and Oophorectomy.

She is actively involved in clinical research, co-authoring 127 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Amsterdam, NH, Netherlands
Other Locations
The Hague, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Open Label Phase I/II Study to Determine the Safety and Immune Modulating Effects of the Therapeutic Human Papilloma Virus 16 (HPV16) E6/E7 Long Peptides Vaccine (ISA101/ISA101b) Immunotherapy in Combination With Standard of Care Therapy (Carboplatin and Paclitaxel With or Without Bevacizumab) in Women With HPV16 Positive Advanced or Recurrent Cervical Cancer Who Have no Curative Treatment Options
A Multicenter, Open Label Phase I/II Study to Determine the Safety and Immune Modulating Effects of the Therapeutic Human Papilloma Virus 16 (HPV16) E6/E7 Long Peptides Vaccine (ISA101/ISA101b) Immunotherapy in Combination With Standard of Care Therapy (Carboplatin and Paclitaxel With or Without Bevacizumab) in Women With HPV16 Positive Advanced or Recurrent Cervical Cancer Who Have no Curative Treatment Options
Enrollment Status: Completed
Publish Date: March 06, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2

127 Total Publications

Neoadjuvant chemotherapy reduces regulatory T-cells in cervical cancer.
Neoadjuvant chemotherapy reduces regulatory T-cells in cervical cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 14, 2026

Frequently Asked Questions about Gemma G. Kenter

Is Gemma G. Kenter a top-rated expert for Cervical Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Gemma G. Kenter is classified as an Elite expert for Cervical Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gemma G. Kenter participate in research or clinical trials?

Yes. Gemma G. Kenter has published 127 articles and abstracts on conditions like Cervical Cancer. You can view a list of Gemma G. Kenter's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Kenter's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile